Home
/
DEXCOM INC
/
Financials
/
Quarterly
DEXCOM INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that DEXCOM INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Sep 30, 2018
$266.70M
Nov 6, 2018
Q2
2018
Jun 30, 2018
$242.50M
Aug 1, 2018
Q1
2018
Mar 31, 2018
$184.40M
May 2, 2018
Q3
2018
Sep 30, 2017
$184.60M
Nov 6, 2018
Q2
2018
Jun 30, 2017
$170.60M
Aug 1, 2018
Q1
2018
Mar 31, 2017
$142.30M
May 2, 2018
Q3
2017
Sep 30, 2016
$148.60M
Nov 1, 2017
Q2
2017
Jun 30, 2016
$137.30M
Aug 1, 2017
Q1
2017
Mar 31, 2016
$116.20M
May 2, 2017
Q3
2016
Sep 30, 2015
$105.20M
Nov 1, 2016
Q2
2016
Jun 30, 2015
$93.20M
Aug 2, 2016
Q1
2015
Mar 31, 2015
$72.80M
Apr 29, 2015
Q3
2015
Sep 30, 2014
$69.00M
Nov 4, 2015
Q2
2015
Jun 30, 2014
$58.80M
Aug 5, 2015
Q1
2015
Mar 31, 2014
$47.10M
Apr 29, 2015
Q3
2014
Sep 30, 2013
$42.90M
Nov 6, 2014
Q2
2014
Jun 30, 2013
$35.80M
Aug 6, 2014
Q1
2014
Mar 31, 2013
$29.60M
May 1, 2014
Q3
2013
Sep 30, 2012
$23.10M
Nov 6, 2013
Q2
2013
Jun 30, 2012
$23.40M
Aug 7, 2013
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.21B
Oct 30, 2025
Q2
2025
Jun 30, 2025
$1.16B
Jul 30, 2025
Q1
2025
Mar 31, 2025
$1.04B
May 1, 2025
Q3
2025
Sep 30, 2024
$994.20M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$1.00B
Jul 30, 2025
Q1
2025
Mar 31, 2024
$921.00M
May 1, 2025
Q3
2024
Sep 30, 2023
$975.00M
Oct 24, 2024
Q2
2024
Jun 30, 2023
$871.30M
Jul 25, 2024
Q1
2024
Mar 31, 2023
$741.50M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$769.60M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$696.20M
Jul 27, 2023
Q1
2023
Mar 31, 2022
$628.80M
Apr 27, 2023
Q3
2022
Sep 30, 2021
$650.20M
Oct 27, 2022
Q2
2022
Jun 30, 2021
$595.10M
Jul 28, 2022
Q1
2022
Mar 31, 2021
$505.00M
Apr 28, 2022
Q3
2021
Sep 30, 2020
$500.90M
Oct 28, 2021
Q2
2021
Jun 30, 2020
$451.80M
Jul 29, 2021
Q1
2021
Mar 31, 2020
$405.10M
Apr 29, 2021
Q3
2020
Sep 30, 2019
$396.30M
Oct 27, 2020
Q2
2020
Jun 30, 2019
$336.40M
Jul 28, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$283.80M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$179.80M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$105.40M
May 1, 2025
Q3
2025
Sep 30, 2024
$134.60M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$143.50M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$146.40M
May 1, 2025
Q3
2024
Sep 30, 2023
$120.70M
Oct 24, 2024
Q2
2024
Jun 30, 2023
$115.90M
Jul 25, 2024
Q1
2024
Mar 31, 2023
$48.60M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$101.20M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$50.90M
Jul 27, 2023
Q1
2023
Mar 31, 2022
$97.30M
Apr 27, 2023
Q3
2022
Sep 30, 2021
$87.30M
Oct 27, 2022
Q2
2022
Jun 30, 2021
$78.40M
Jul 28, 2022
Q1
2022
Mar 31, 2021
$56.50M
Apr 28, 2022
Q3
2021
Sep 30, 2020
$72.20M
Oct 28, 2021
Q2
2021
Jun 30, 2020
$46.30M
Jul 29, 2021
Q1
2021
Mar 31, 2020
$19.90M
Apr 29, 2021
Q3
2020
Sep 30, 2019
$45.80M
Oct 27, 2020
Q2
2020
Jun 30, 2019
($10.50M)
Jul 28, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$242.50M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$212.60M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$133.70M
May 1, 2025
Q3
2025
Sep 30, 2024
$152.00M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$158.00M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$101.10M
May 1, 2025
Q3
2024
Sep 30, 2023
$205.50M
Oct 24, 2024
Q2
2024
Jun 30, 2023
$128.10M
Jul 25, 2024
Q1
2024
Mar 31, 2023
$47.20M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$147.50M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$77.00M
Jul 27, 2023
Q1
2023
Mar 31, 2022
$41.30M
Apr 27, 2023
Q3
2022
Sep 30, 2021
$118.30M
Oct 27, 2022
Q2
2022
Jun 30, 2021
$101.00M
Jul 28, 2022
Q1
2022
Mar 31, 2021
$45.90M
Apr 28, 2022
Q3
2021
Sep 30, 2020
$94.10M
Oct 28, 2021
Q2
2021
Jun 30, 2020
$67.80M
Jul 29, 2021
Q1
2021
Mar 31, 2020
$33.60M
Apr 29, 2021
Q3
2020
Sep 30, 2019
$56.00M
Oct 27, 2020
Q2
2020
Jun 30, 2019
($800.0K)
Jul 28, 2020